Martinez, PriscillaTsai, Alexander C.Muzoora, ConradKembabazi, AnnetWeiser, Sheri D.Huang, YongHaberer, Jessica E.Martin, Jeffrey N.Bangsberg, David R.Hunt, Peter W.2022-01-312022-01-312014Martinez, P., Tsai, A. C., Muzoora, C., Kembabazi, A., Weiser, S. D., Huang, Y., ... & Hunt, P. W. (2014). Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans. Journal of acquired immune deficiency syndromes (1999), 65(4), 456.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3943704/https://nru.uncst.go.ug/xmlui/handle/123456789/1689Major depressive disorder is highly prevalent among HIV-infected persons, and depression symptom severity improves during the course of HIV antiretroviral therapy (ART). The potential biologic pathways explaining these phenomena remain unclear. We investigated the extent to which ART-mediated suppression of the kynurenine pathway of tryptophan catabolism (via indoleamine 2,3- dioxygenase-1 and potentially other sources) may correlate with improvements in depression symptom severity in this setting.enTryptophan catabolismIndoleamine 23-dioxygenase-1DepressionAntiretroviral therapySub-Saharan AfricaArticle